UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021-01, Vol.14, p.17562864211012835-17562864211012835

2021

Volltextzugriff (PDF)

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241266113

2024

Volltextzugriff (PDF)

Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity

Annals of neurology, 2004-03, Vol.55 (3), p.410-417

2004

Volltextzugriff (PDF)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.175628642110200-17562864211020082

2021

Volltextzugriff (PDF)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Multiple sclerosis, 2021-05, Vol.27 (6), p.864-870

2021

Volltextzugriff (PDF)

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Journal of neurology, 2022-05, Vol.269 (5), p.2286-2292

2022

Volltextzugriff (PDF)

Mapping brain volume change across time in primary-progressive multiple sclerosis

Neuroradiology, 2024-07, Vol.66 (7), p.1189-1197

2024

Volltextzugriff (PDF)

Parity and disability progression in relapsing–remitting multiple sclerosis

Journal of neurology, 2020-12, Vol.267 (12), p.3753-3762

2020

Volltextzugriff (PDF)

Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome

Multiple sclerosis, 2014-01, Vol.20 (1), p.35-42

2014

Volltextzugriff (PDF)

Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study

European journal of paediatric neurology, 2024-05, Vol.50, p.81-85

2024

Volltextzugriff (PDF)

Acute effects of aerobic intensities on the cytokine response in women with mild multiple sclerosis

Multiple sclerosis and related disorders, 2019-06, Vol.31, p.82-86

2019

Volltextzugriff (PDF)

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy

Multiple sclerosis, 2019-11, Vol.25 (13), p.1746-1753

2019

Volltextzugriff (PDF)

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab

Multiple sclerosis and related disorders, 2023-04, Vol.72, p.104616-104616, Article 104616

2023

Volltextzugriff (PDF)

A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation

Annals of neurology, 2012-04, Vol.71 (4), p.509-519

2012

Volltextzugriff (PDF)

Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression

Multiple sclerosis and related disorders, 2021-05, Vol.50, p.102814-102814, Article 102814

2021

Volltextzugriff (PDF)

Neural Cell Adhesion Molecule (NCAM) a Serum Biomarker Indicative for the Severity of Cervical Spondylotic Myelopathy

Clinical spine surgery, 2020-05, Vol.33 (4), p.E178-E184

2020

Volltextzugriff (PDF)

Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients

Annals of clinical and translational neurology, 2021-01, Vol.8 (1), p.81-94

2021

Volltextzugriff (PDF)

Optimizing multiple sclerosis diagnosis: gene expression and genomic association

Annals of clinical and translational neurology, 2015-03, Vol.2 (3), p.271-277

2015

Volltextzugriff (PDF)

Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

BMC neurology, 2015-11, Vol.15 (240), p.240-240, Article 240

2015

Volltextzugriff (PDF)

Do motor impairments detected on onset of multiple sclerosis suggest an early second attack? A prospective study

NeuroRehabilitation (Reading, Mass.), 2013-01, Vol.33 (3), p.423-430

2013

Volltextzugriff (PDF)

Subjective memory complaints in elders: depression, anxiety, or cognitive decline?

Acta neurologica Scandinavica, 2013-05, Vol.127 (5), p.344-350

2013

Volltextzugriff (PDF)

SLC30A9 mutation affecting intracellular zinc homeostasis causes a novel cerebro-renal syndrome

Brain (London, England : 1878), 2017-04, Vol.140 (4), p.928-939

2017

Volltextzugriff (PDF)

Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance

Movement disorders, 2020-10, Vol.35 (10), p.1755-1764

2020

Volltextzugriff (PDF)

Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

Movement disorders, 2010-11, Vol.25 (15), p.2604-2612

2010

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaClinical Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Mapping brain volume change across time in primary-progressive multiple sclerosis

Parity and disability progression in relapsing–remitting multiple sclerosis

Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome

Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study

Acute effects of aerobic intensities on the cytokine response in women with mild multiple sclerosis

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab

A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation

Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression

Neural Cell Adhesion Molecule (NCAM) a Serum Biomarker Indicative for the Severity of Cervical Spondylotic Myelopathy

Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients

Optimizing multiple sclerosis diagnosis: gene expression and genomic association

Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

Do motor impairments detected on onset of multiple sclerosis suggest an early second attack? A prospective study

Subjective memory complaints in elders: depression, anxiety, or cognitive decline?

SLC30A9 mutation affecting intracellular zinc homeostasis causes a novel cerebro-renal syndrome

Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance

Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry

Red flags for multiple system atrophy

Aktive Filter

Suchergebnisse filtern